The Delhi High Court's ruling in Array Biopharma Inc. v. Deputy Controller clarifies that patent objections must be substantiated by evidence linked to the claims, highlighting judicial scrutiny in patent examination.
Delhi HC Emphasizes Evidence in Patent Objections
The Delhi High Court's recent decision in Array Biopharma Inc. v. Deputy Controller of Patents underscores the necessity for patent objections to be anchored in concrete evidence rather than vague assertions. This ruling reiterates a critical principle that objection to patent claims must directly relate to the evidence provided.
The case brought forth important considerations regarding inventive steps and specific sections of the Patent Act, particularly Sections 3(d) and 3(i). The judgement noted that establishing a connection between objections and the applicant's claims is essential for any challenge to be valid.
While the ruling affirms existing legal standards, it also raises further inquiries regarding the procedural expectations for substantive evidence in patent disputes. The articulation of this principle not only bolsters the protection of intellectual property but also enhances the integrity of the examination process.
Legal practitioners must now ensure that their objections are meticulously substantiated with relevant evidence, as the Delhi High Court's scrutiny may serve as a benchmark for future patent proceedings.
Citations
- Array Biopharma Inc. (2026) DHC
